Abbott India is gearing up to give Breakout.
Company's Overview.
Abbott India Ltd is one of the market leader and multinational pharmaceutical company in India with a global presence in over 160 countries. It has a legacy of more than 130 years in the industry.
Revenue Breakup.
In FY22, injectables contributed around 40% of the revenues, followed by tablets at 39%, liquids at approximately 16%, capsules at 3%, and other products at 2%.
Financials.
>>Almost debt free company.
>>ROCE- 41.1%, Which is considered to be an excellent return.
>>Good growth can be seen in net profit margin.
>>Maintaining a healthy dividend payout of 76.8%.
Technical.
As we have seen Last week, all chemical stocks had a good rally. It looks like this rally will continue further. So we will keep a close track on this stock because it still falls under one of the undervalued stock category.
This stock was consolidating within an uptrend parallel channel. Last week, it closed near its resistance level.
If it breaks out with a big candle and significant volume, we can enter the trade. We'll use a 1:1 risk-reward management strategy for this trade as explained in chart.
This is my Analysis, I might be wrong sometimes Please do your 'own' due diligence before taking trades.
Abbott India Ltd is one of the market leader and multinational pharmaceutical company in India with a global presence in over 160 countries. It has a legacy of more than 130 years in the industry.
Revenue Breakup.
In FY22, injectables contributed around 40% of the revenues, followed by tablets at 39%, liquids at approximately 16%, capsules at 3%, and other products at 2%.
Financials.
>>Almost debt free company.
>>ROCE- 41.1%, Which is considered to be an excellent return.
>>Good growth can be seen in net profit margin.
>>Maintaining a healthy dividend payout of 76.8%.
Technical.
As we have seen Last week, all chemical stocks had a good rally. It looks like this rally will continue further. So we will keep a close track on this stock because it still falls under one of the undervalued stock category.
This stock was consolidating within an uptrend parallel channel. Last week, it closed near its resistance level.
If it breaks out with a big candle and significant volume, we can enter the trade. We'll use a 1:1 risk-reward management strategy for this trade as explained in chart.
This is my Analysis, I might be wrong sometimes Please do your 'own' due diligence before taking trades.
Thông báo miễn trừ trách nhiệm
Thông tin và ấn phẩm không có nghĩa là và không cấu thành, tài chính, đầu tư, kinh doanh, hoặc các loại lời khuyên hoặc khuyến nghị khác được cung cấp hoặc xác nhận bởi TradingView. Đọc thêm trong Điều khoản sử dụng.